Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intersect Ent Inc (NQ: XENT ) 28.24 UNCHANGED Last Price Updated: 4:00 PM EDT, May 12, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 28.24 Bid (Size) 28.24 (1,000) Ask (Size) 29.25 (200) Prev. Close 28.24 Today's Range 28.24 - 28.24 52wk Range N/A - N/A Shares Outstanding 33,314,586 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Real-World Evidence Study Demonstrates Intersect ENT’s PROPEL® Sinus Implant Reduces Healthcare Resource Utilization January 25, 2022 From Intersect ENT, Inc. Via Business Wire Intersect ENT Reports Third Quarter 2021 Financial Results November 02, 2021 From Intersect ENT, Inc. Via Business Wire Performance More News Read More First Implants of PROPEL® Contour in Patients with Chronic Rhinosinusitis Following Frontal Sinus Surgery in Europe October 28, 2021 From Intersect ENT®, Inc. Via Business Wire SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, LMRK, XENT, JAX; Shareholders are Encouraged to Contact the Firm September 13, 2021 From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates INOV, GTS, XONE, XENT; Shareholders are Encouraged to Contact the Firm September 04, 2021 From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CSOD, XENT, FFWM, RIVE; Shareholders are Encouraged to Contact the Firm August 19, 2021 From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal INVESTIGATION: Halper Sadeh LLP Investigates NLOK, XENT, NWHM; Shareholders are Encouraged to Contact the Firm August 12, 2021 From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021 August 12, 2021 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2021 August 09, 2021 Via Benzinga The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering August 11, 2021 Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts August 10, 2021 Via Benzinga Exposures COVID-19 INTERSECT ENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intersect ENT - XENT August 06, 2021 From Kahn Swick & Foti, LLC Via Business Wire Why Intersect ENT Shot 12% Higher on Friday August 06, 2021 Via The Motley Fool Intersect ENT Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Intersect ENT, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – XENT August 06, 2021 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Friday's Intraday Session August 06, 2021 Via Benzinga Medtronic Expands Its ENT Portfolio With Intersect ENT Acquisition For $28.25/Share August 06, 2021 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session August 06, 2021 Via Benzinga Intersect ENT: Q2 Earnings Insights August 06, 2021 Via Benzinga Intersect ENT Reports Second Quarter 2021 Financial Results August 06, 2021 From Intersect ENT, Inc. Via Business Wire U.S Nationwide Commercial Availability of the VenSure™ Balloon Sinus Dilation System and Cube™ Navigation System Highlight Intersect ENT’s Continued Commitment to Providing Innovative, Solutions for Patients with Chronic Rhinosinusitis July 26, 2021 From Intersect ENT Via Business Wire Earnings Scheduled For August 6, 2021 August 06, 2021 Via Benzinga Intersect ENT Sees Q2 Sales Lag Wall Street Estimates; Raises $60M In Debt Funding July 23, 2021 Via Benzinga Intersect ENT to Report Second Quarter 2021 Financial Results on August 6 July 23, 2021 From Intersect ENT, Inc. Via Business Wire Intersect ENT Announces Preliminary Revenue for Second Quarter of 2021 and Closing of $60 Million Term Loan July 22, 2021 From Intersect ENT, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 June 24, 2021 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.